Key Takeaways
- Piper Sandler launched coverage of Rocket Lab (RKLB) with a Neutral stance and $83 price objective
- Shares currently hover between $66 and $76, marking a significant decline, with concerns about elevated valuation metrics
- On July 7, CEO Peter Beck offloaded 1.3 million shares at $84.92 through a pre-established 10b5-1 trading arrangement
- Latest quarterly revenue surged 63.4% compared to the prior year, reaching $200.35 million and surpassing projections
- Morgan Stanley maintains an Overweight position with a $105 target; average analyst consensus stands at $110.18
Rocket Lab (RKLB) shareholders have endured a challenging period recently. The aerospace company’s shares have plummeted approximately 13%, now changing hands near $66—a stark contrast to the $151 peak reached within the past year.
On Wednesday, Piper Sandler launched its coverage of the space technology company with a Neutral designation alongside an $83 price objective. The investment firm arrived at this valuation by applying a 39x multiple to the company’s projected fiscal 2027 enterprise value-to-revenue metric.
With a market capitalization hovering between $41.5 billion and $44 billion, Rocket Lab finds itself under scrutiny. According to InvestingPro analysis, the shares appear stretched beyond their Fair Value benchmark, sporting a Price/Book multiple of 18.88.
The company commands a higher enterprise value-to-revenue multiple compared to SpaceX. Piper Sandler anticipates this premium pricing dynamic will persist throughout the next twelve months.
Yet despite these valuation concerns, RKLB has generated impressive returns of 59.78% over the trailing year while accelerating revenue growth by 45.83% during the same timeframe. The momentum behind this business remains undeniable.
Robust Operating Results Overshadowed by Valuation Debate
The company’s latest financial disclosure painted an encouraging picture. First-quarter revenue reached $200.35 million, representing a robust 63.4% year-over-year expansion and exceeding Wall Street’s $189.65 million forecast.
Earnings per share registered at -$0.07, aligning with analyst projections. For the full fiscal year, the Street anticipates an EPS of -$0.26.
A significant technical achievement came with the successful full-duration test of the Neutron rocket engine—a critical validation point ahead of the larger vehicle’s inaugural flight. Industry observers viewed this development favorably.
Rocket Lab made headlines with its recently finalized $8 billion acquisition of Iridium Communications. Following this announcement, Morgan Stanley confirmed its Overweight recommendation while maintaining a $105 price objective.
Cantor Fitzgerald similarly upheld its Overweight view after the company’s successful execution of the U.S. Space Force VICTUS HAZE mission, establishing a $96 price target.
Substantial Insider Selling Draws Attention
CEO Peter Beck executed a sale of 1,298,622 shares on July 7, receiving an average price of $84.92 per share. The transaction generated proceeds exceeding $110 million and occurred through a previously established Rule 10b5-1 trading program.
Following this divestiture, Beck retains ownership of 2,715,181 shares with an approximate market value of $230 million.
Collectively, company insiders have disposed of 3,849,294 shares valued at roughly $362.8 million during the previous three-month window. Each of these transactions occurred under pre-arranged 10b5-1 frameworks.
Calamos Advisors dramatically reduced its RKLB holdings by 90.1% during the first quarter, scaling back from 245,980 shares to just 24,393 shares worth approximately $1.57 million.
Despite these sales, institutional investors collectively control 71.78% of outstanding shares.
Technically, the stock trades beneath both its 50-day moving average of $108.95 and its 200-day moving average of $87.31, signaling near-term weakness.
Wall Street’s consensus recommendation sits at Moderate Buy, with an average price target of $110.18. Wells Fargo anchors the low end at $60, while New Street Research maintains a Buy rating with an ambitious $150 target.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
